2D-nanomaterials for AKI treatment
Qiaohui Chen1,2, Xiaoyuan Wang2,3, Chao Yuan2,3
1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Frontiers in Bioengineering and Biotechnology
|March 27, 2023
Summary
Two-dimensional nanomaterials offer a promising new approach to treating acute kidney injury (AKI). These advanced materials show significant advantages over conventional therapies for managing kidney damage caused by oxidative stress.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nephrology
Background:
- Acute kidney injury (AKI) poses significant risks to hospitalized patients, characterized by high morbidity, mortality, and poor prognosis.
- Redox imbalance, driven by reactive oxygen species in renal tubules, is a primary cause of kidney damage in AKI.
- Conventional antioxidant drugs have limited efficacy in AKI management, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review recent advancements in the application of two-dimensional (2D) nanomaterials for treating AKI.
- To highlight the therapeutic potential of 2D nanomaterials in overcoming the limitations of current AKI treatments.
- To discuss future opportunities and challenges in developing 2D nanomaterial-based therapies for AKI.
Main Methods:
- Review of recent scientific literature on 2D nanomaterials for AKI therapy.
- Focus on specific 2D nanomaterials such as DNA origami, germanene, and MXene.
- Analysis of the unique properties of 2D nanomaterials, including their ultrathin structure, large surface area, and kidney targeting capabilities.
Main Results:
- 2D nanomaterials demonstrate significant advantages in AKI therapy due to their unique structural and physicochemical properties.
- Specific examples like DNA origami, germanene, and MXene show promise in preclinical AKI models.
- Nanotechnology-mediated antioxidant therapies offer a potent strategy for AKI management.
Conclusions:
- 2D nanomaterials represent a promising frontier for developing effective AKI treatments.
- Further research into novel 2D nanomaterials is crucial for advancing AKI therapy.
- This review provides insights and theoretical support for future development in the field of 2D nanomaterials for AKI.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
46
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
46
Acute Kidney Injury II: Pathophysiology
38
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
38
Acute Kidney Injury I: Introduction
43
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
43
Acute Kidney Injury V: Interprofessional Care
35
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
35
Acute Kidney Injury VI: Nursing Management
41
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
41
Acute Kidney Injury III: Clinical Manifestations
50
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
50


